Kura Oncology Logo
Kura Oncology to Participate in the 2016 Aegis Growth Conference
September 14, 2016 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced its participation in the 2016 Aegis Growth...
Kura Oncology Logo
Kura Oncology to Participate in the 5th Annual Gateway Conference
September 02, 2016 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Sept. 02, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced its participation in the 2016 Gateway...
Kura Oncology Logo
Kura Oncology Reports Second Quarter 2016 Financial Results
August 10, 2016 16:03 ET | Kura Oncology, Inc.
Promising clinical activity observed in Phase 2 trial of tipifarnib in HRAS mutant solid tumors has triggered additional patient enrollment Management to host webcast and conference call today at...
Kura Oncology Logo
Kura Oncology to Report Second Quarter 2016 Financial Results
August 03, 2016 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced it will report second quarter 2016 financial...
Kura Oncology Logo
Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Lower Risk Myelodysplastic Syndromes
June 16, 2016 17:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced the first patient has been dosed in a Phase 2...
Kura Oncology Logo
Kura Oncology to Participate in the Jefferies 2016 Healthcare Conference
June 03, 2016 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced its participation in the Jefferies 2016...
Kura Oncology Logo
Kura Oncology Reports First Quarter 2016 Financial Results
May 11, 2016 16:05 ET | Kura Oncology, Inc.
LA JOLLA, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (NASDAQ:KURA) a clinical stage biopharmaceutical company, today reported financial results for the first quarter ended March...
Kura Oncology Logo
Kura Oncology Reports Fourth Quarter and Full Year 2015 Operational and Financial Results
March 17, 2016 16:05 ET | Kura Oncology, Inc.
LA JOLLA, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (NASDAQ:KURA) a clinical stage biopharmaceutical company, today announced highlights and financial results for the fourth...
Kura Oncology Logo
Kura Oncology to Report Fourth Quarter and Full Year 2015 Financial Results
March 11, 2016 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., March 11, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that it will report fourth quarter and full year...
Kura Oncology Logo
Kura Oncology to Participate in the Leerink Global Healthcare Conference
February 04, 2016 07:00 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and...